Literature DB >> 12904692

Different proliferative and apoptotic activity in peripheral versus central parts of human uterine leiomyomas.

Vladimir Bourlev1, Stanislav Pavlovitch, Denis Stygar, Nikolai Volkov, Bo Lindblom, Matts Olovsson.   

Abstract

OBJECTIVE: To determine whether there are differences in proliferative and apoptotic activity and in expression of sex steroid receptors between central and peripheral parts of human uterine leiomyomas in different menstrual cycle phases.
METHODS: Biopsy specimens of the myometrium and peripheral and central parts of uterine leiomyomas were obtained from 15 women in the proliferative phase and 8 women in the secretory phase. Mitotic cells were detected by immunohistochemical staining for Ki67. Apoptotic cells were detected by the TUNEL method. Mitotic and apoptotic indexes were calculated. Tissue levels of oestrogen and progesterone receptors were measured using a commercial monoclonal receptor enzyme immunoassay kit.
RESULTS: During the secretory phase the mitotic index was significantly higher in the peripheral than in the central parts of the leiomyomas. During the proliferative phase the apoptotic index was significantly higher in the peripheral compared with the central parts. These differences were not reflected by differences in receptor expression.
CONCLUSIONS: The results of this study suggest that the growth of a human uterine leiomyoma mainly occurs in the peripheral parts of the tumour, during the secretory phase of the menstrual cycle. The findings emphasise the importance of being consistent when taking samples for research work. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904692     DOI: 10.1159/000072074

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  5 in total

Review 1.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

2.  Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium.

Authors:  Tonia L Hermon; Alicia B Moore; Linda Yu; Grace E Kissling; Frank J Castora; Darlene Dixon
Journal:  Virchows Arch       Date:  2008-10-14       Impact factor: 4.064

3.  Relaxin increases elastase activity and protease inhibitors in smooth muscle cells from the myometrium compared with cells from leiomyomas.

Authors:  Bertha Chen; Yan Wen; Xiao Yun Yu; Mary Lake Polan
Journal:  Fertil Steril       Date:  2008-06-12       Impact factor: 7.329

4.  PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes PTEN & LKB1 in human uterine leiomyomas.

Authors:  Annu Makker; Madhu Mati Goel; Abbas Ali Mahdi; Vikram Bhatia; Vinita Das; Anjoo Agarwal; Amita Pandey
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

5.  Establishment of a novel mouse xenograft model of human uterine leiomyoma.

Authors:  Yusuke Suzuki; Masaaki Ii; Takashi Saito; Yoshito Terai; Yasuhiko Tabata; Masahide Ohmichi; Michio Asahi
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.